Phathom Pharmaceuticals (PHAT) Raw Materials (2023 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly Raw Materials of $6.2 million for Q2 2026, up 527.35% year-over-year from $991000.0 in Q2 2025, and up 23.7% quarter-over-quarter from $5.0 million in Q1 2026.
Phathom Pharmaceuticals (PHAT) Raw Materials (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Raw Materials for 4 consecutive years, with $6.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Raw Materials rose 527.35% year-over-year to $6.2 million; the TTM figure through Jun 2026 stood at $6.2 million (up 527.35% YoY), while the FY2025 annual figure was $4.1 million, up 134.88% from the prior year.
- Raw Materials improved to $6.2 million in Q2 2026 per PHAT's latest filing, from $5.0 million in the prior quarter.
- Across five years, Raw Materials topped out at $6.2 million in Q2 2026 and bottomed at $111000.0 in Q2 2023.
- Historically, Raw Materials has averaged $1.9 million across 4 years, with a median of $1.3 million in 2024.
- Annual changes were most pronounced in 2024 — Raw Materials surged 1717.12% — and 2025, when it sank 50.02%.
- Phathom Pharmaceuticals' Raw Materials stood at $561000.0 in 2023, then soared by 208.2% to $1.7 million in 2024, then jumped by 134.88% to $4.1 million in 2025, then jumped by 53.09% to $6.2 million in 2026.
- Business Quant data shows PHAT's Raw Materials at $6.2 million in Q2 2026, $5.0 million in Q1 2026, and $4.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.22 Mn |
| Mar 31, 2026 | 5.03 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 991,000.00 |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Sep 30, 2024 | 2.02 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 640,000.00 |
| Dec 31, 2023 | 561,000.00 |
| Sep 30, 2023 | 111,000.00 |
| Jun 30, 2023 | 111,000.00 |